Effects of dehydroepiandrosterone (DHEA) on ubiquinone and catalase in the livers of male F-344 rats

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 7, 2005, Pages 1301-1303

  Khan, Seher Akhtar ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Liver; Oxidative stress; Peroxisome; Tumor; Ubiquinone

Indexed keywords

CATALASE; LIPID PEROXIDE; PRASTERONE; UBIDECARENONE; UBIQUINONE; UBIQUINONE 9; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER; MALE; NONHUMAN; PROTEIN CONTENT; RAT; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ANIMALS; CATALASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEHYDROEPIANDROSTERONE; LIPID PEROXIDES; LIVER; MALE; RATS; RATS, INBRED F344; UBIQUINONE;

EID: 24944550446     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1301     Document Type: Article

References (31)

1. Zumoff B., Rosenfeld R. S., Strain G. W., Levin J., Fukushima D. K., J. Clin. Endocrinol. Metab., 51, 330-333 (1980).
2. Gordon G. B., Helzlsouer K. J., Comstock G. W., Cancer Res., 51, 1366-1369 (1991).
3. Gordon G. B., Helzlsouer K. J., Alberg A. J., Comstock G. W., Cancer Epidemiol. Biomarkers Prev., 2, 33-35 (1993).
4. Barrett-Connor E., Khaw K. T., Yen S. S., N. Engl. J. Med., 315, 1519-1524 (1986).
5. Nyce J. W., Magee P. N., Hard G. C., Schwartz A. G., Carcinogenesis, 5, 57-62 (1984).
6. Pashko L. L., Hard G. C., Rovito R. J., Williams J. R., Sobel E. L., Schwartz A. G., Cancer Res., 45, 164-166 (1985).
7. Schwartz A. G., Cancer Res., 39, 1129-1132 (1979).
8. Schwartz A. G., Tannen R. H., Carcinogenesis, 2, 1335-1337 (1981).
9. Coleman D. L., Leiter E. H., Schwizer R. W., Diabetes, 31, 830-833 (1982).
10. Yen T. T., Allan J. A., Pearson D. V., Acton J. M., Greenberg M. M., Lipids, 12, 409-413 (1977).
11. Rao M. S., Subbarao V., Yeldandi A. V., Reddy J. K., Cancer Res., 52, 2977-2979 (1992).
12. Sakuma M., Yamada J., Suga T., Biochem. Pharmacol., 43, 1269-1273 (1992).
13. Hayashi F., Tamura H., Yamada J., Kasai H., Suga T., Carcinogenesis, 15, 2215-2219 (1994).
14. McIntosh M. K., Goldfarb A. H., Curtis L. N., Cote P. S., J. Nutr., 123, 216-224 (1993).
15. Schulz S., Klann R. C., Schonfeld S., Nyce J. W., Cancer Res., 52, 1372-1376 (1992).
16. Yamada J., Sakuma M., Ikeda T., Fukuda K., Suga T., Biochim. Biophys. Acta, 1092, 233-243 (1991).
17. Borges T., Glauert H. P., Robertson L. W., Toxicol. Appl. Pharmacol., 118, 8-15 (1993).
18. Aebi H., "Methods of Enzymatic Analysis," ed. by Bergmeyer H. U., Academic Press, New York, 1974.
19. Reahal S., Wrigglesworth J., Drug Metab. Dispos., 20, 423-427 (1992).
20. Okamoto T., Fukui K., Nakamoto M., Kishi T., Okishio T., Yamagami T., Kanamori N., Kishi H., Hiraoka E., J. Chromatogr., 342, 35-46 (1985).
21. Lang J. K., Packer L., J. Chromatogr., 385, 109-117 (1987).
22. Beyer R. E., Burnett B. A., Cartwright K. J., Edington D. W., Falzon M. J., Kreitman K. R., Kuhn T. W., Ramp B. J., Rhee S. Y., Rosenwasser M. J., Stein M., An L.C., Mech. Ageing Dev., 32, 267-281 (1985).
23. De A. K., Darad R., Mech. Ageing Dev., 59, 123-128 (1991).
24. Forsmark-Andree P., Ernster L., Mol. Aspects Med., 15, s73-s81 (1994).
25. Khan S. A., Pharmazie, 59, 491-492 (2004).
26. Aberg F., Zhang Y., Teclebrhan H., Appelkvist E. L., Dallner G., Chem. Biol. Interact., 99, 205-218 (1996).
27. Swierczynski J., Bannasch P., Mayer D., Biochim. Biophys. Acta, 1315, 193-198 (1996).
28. Swierczynski J., Mayer D., J. Steroid Biochem. Mol. Biol., 58, 599-603 (1996).
29. Turunen M., Peters J. M., Gonzalez F. J., Schedin S., Dallner G., J. Mol. Biol., 297, 607-614 (2000).
30. Peters J. M., Zhou Y. C., Ram P. A., Lee S. S., Gonzalez F. J., Waxman D. J., Mol. Pharmacol., 50, 67-74 (1996).
31. Khan S. A., Nyce J. W., Pharmacol. Toxicol., 80, 118-121 (1997).